We use cookies on this site to enhance your user experience and to remember your preferences. By continuing to browse our website, you are agreeing to our use of cookies. To find out more about these cookies, click here.
|
For the three months ended |
For the years ended |
||||
|---|---|---|---|---|---|
|
(In millions of canadian dollars, except per share amounts or as otherwise noted) |
March 31 |
Dec. 31 |
March 31 |
December 31 |
December 31 |
|
Revenues(1) |
10,856 |
14,043 |
13,809 |
51,362 |
50,750 |
|
Net earnings attributable to participating shareholders |
525 |
208 |
258 |
1,286 |
1,082 |
|
Net earnings per participating share |
1.13 |
0.44 |
0.56 |
2.77 |
2.33 |
|
Adjusted net earnings attributable to participating shareholders(2, 3) |
525 |
419 |
269 |
1,560 |
1,223 |
|
Adjusted net earnings per participating share(2, 3) |
1.13 |
0.90 |
0.58 |
3.36 |
2.64 |
|
Dividends declared per participating share |
0.3585 |
0.3585 |
0.3350 |
1.4105 |
1.3163 |
|
Consolidated assets(4) |
457,902 |
445,521 |
429,619 |
445,521 |
422,724 |
|
Shareholders' equity |
15,109 |
14,615 |
14,139 |
14,615 |
13,864 |
|
Book value per participating share |
30.44 |
29.40 |
28.40 |
29.40 |
27.84 |
|
Participating shares outstanding (in millions) |
464.7 |
464.3 |
463.8 |
464.3 |
463.3 |
(1) Comparative figures for 2017 have been adjusted as a result of IFRS 15 as described in Note 3 to the Corporation's March 31, 2018 Consolidated Interim unaudited Financial Statements.
(2) Adjusted net earnings attribuable to participating shareholders and adjusted net earnings per participating share are non-IFRS financial measures. Refer to the section "Non-IFRS Measures and Presentation" of the Corporation's most recent management's discussion and analysis for the definition and reconciliation of the IFRS and non-IFRS measures.
(3) Comparative figures for 2016 have been adjusted to reflect other items reported by Lifeco.
(4) Comparative figures have been retrospectively adjusted as described in Note 16 to the Corporation's 2017 Consolidated Financial Statements.
|
As at and for the years ended December 31 [in millions of Canadian dollars, except as otherwise noted] |
2017 |
2016 |
2015 |
2014 |
2013 |
|---|---|---|---|---|---|
|
Consolidated Balance Sheets |
|||||
|
Cash and cash equivalents |
5,903 |
5,182 | 5,085 | 4,431 |
4,767 |
|
Total assets(1) |
445,521 |
422,724 | 422,859 | 377,781 |
344,976 |
|
Shareholders’ equity(2) |
14,615 |
13,864 | 13,978 | 11,931 |
10,924 |
|
Consolidated Statements of Earnings |
|||||
|
Revenues |
|||||
|
Premium income, net(3) |
33,880 |
31,125 | 24,501 | 21,222 |
20,236 |
|
Investment income, net |
8,074 |
10,335 | 4,869 | 13,706 |
2,752 |
|
Fee income(3) |
8,510 |
7,794 | 7,692 | 6,990 |
5,933 |
| Other revenues |
898 |
1,496 | 1,203 | 711 |
721 |
|
51,362 |
50,570 | 38,265 | 42,629 |
29,642 |
|
|
Expenses |
|||||
|
Total paid or credited to policyholders |
35,643 |
34,675 | 22,842 | 29,160 |
17,811 |
|
Commissions(3) |
3,712 |
3,590 | 3,133 | 2,901 |
2,590 |
|
Operating and administrative expenses(3) |
8,132 |
8,023 | 7,239 | 6,066 |
5,448 |
|
Financing charges |
512 |
490 | 480 | 457 |
440 |
|
|
47,999 |
46,778 | 33,694 | 38,584 |
26,289 |
|
3,363 |
3,972 | 4,571 | 4,045 |
3,353 |
|
|
Share of earnings (losses) of investments in jointly controlled corporations and associates |
214 |
(122) | 213 | 215 |
106 |
|
Earnings before income taxes |
3,577 |
3,850 | 4,784 | 4,260 |
3,459 |
|
Income taxes |
543 |
587 | 685 | 824 |
670 |
|
Net earnings |
3,034 |
3,263 | 4,099 | 3,436 |
2,789 |
|
Attributable to |
|||||
|
Non-controlling interests |
1,696 |
2,129 | 2,261 | 2,109 |
1,760 |
|
Non-participating shareholders |
52 |
52 |
52 |
52 |
52 |
|
Participating shareholders |
1,286 |
1,082 | 1,786 | 1,275 |
977 |
|
3,034 |
3,263 | 4,099 | 3,436 |
2,789 |
|
|
Per share |
|||||
|
Net earnings attributable to participating shareholders |
2.77 |
2.33 | 3.86 | 2.77 |
2.12 |
|
Adjusted net earnings(4) attributable to participating shareholders(5, 6) |
3.36 |
2.64 | 3.40 | 2.69 |
2.08 |
|
Dividends declared on participating shares |
1.41 |
1.32 | 1.22 | 1.16 |
1.16 |
|
Book value at year-end(2) |
29.40 |
27.84 | 28.08 | 23.74 |
21.61 |
|
Market price (Participating shares) |
|||||
|
High |
33.68 |
31.03 | 34.57 | 32.87 |
32.82 |
|
Low |
28.65 |
26.77 | 27.15 | 27.60 |
25.02 |
|
Year-end |
32.37 |
30.05 | 28.94 | 31.76 |
31.95 |
(1) Comparative figures have been retrospectively adjusted as described in Note 16 to the Corporation's 2017 Consolidated Financial Statements.
(2) Comparative figures for 2015 have been retrospectively adjusted.
(3) Comparative figures for 2017 have been adjusted as a result of IFRS 15 as described in Note 3 to the Corporation's March 31, 2018 Consolidated Interim unaudited Financial Statements.
(4) Previously described as operating earnings.
(5) Adjusted net earnings per share is a non-IFRS financial measures. Refer to the section "Non-IFRS Measures and Presentation" of the Corporation's most recent management's discussion and analysis for the definition and reconciliation of the IFRS and non-IFRS measures.
(6) Comparative figures for 2016 have been adjusted to reflect other items reported by Lifeco.